Medtech InsightA couple of joint ventures were throw in the deal mix for March and April, including one that would give a French company entry into the lucrative China market. Theraclion SAS , based in Malakoff,
In VivoIN VITRO DIAGNOSTICS Financings Biocept Inc. Biocept Inc. (blood-based molecular diagnostics for solid tumors) netted $8.7mm through the sale of 4.3mm common shares at $2.15 (a slight discount) to
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions that occurred from March 8-28. Deal